0
After GWAS: Searching for Genetic Risk for Schizophrenia and Bipolar Disorder
Elliot S. Gershon, M.D.; Ney Alliey-Rodriguez, M.D.; Chunyu Liu, Ph.D.
CME   Relationship of Personality Disorders to the Course of Major Depressive Disorder in a Nationally Representative Sample
Andrew E. Skodol, M.D.; Carlos M. Grilo, Ph.D.; Katherine M. Keyes, M.P.H., Ph.D.; Timothy Geier, B.A.; Bridget F. Grant, Ph.D.; Deborah S. Hasin, Ph.D.
Pharmacogenetic Approach at the Serotonin Transporter Gene as a Method of Reducing the Severity of Alcohol Drinking
Bankole A. Johnson, D.Sc., M.D.; Nassima Ait-Daoud, M.D.; Chamindi Seneviratne, M.D.; John D. Roache, Ph.D.; Martin A. Javors, Ph.D.; Xin-Qun Wang, M.S.; Lei Liu, Ph.D.; J. Kim Penberthy, Ph.D.; Carlo C. DiClemente, Ph.D.; Ming D. Li, Ph.D.
Prefrontal Cortical Deficits and Impaired Cognition-Emotion Interactions in Schizophrenia
Stefan Ursu, M.D., Ph.D.; Ann M. Kring, Ph.D.; Marja Germans Gard, Ph.D.; Michael J. Minzenberg, M.D.; Jong H. Yoon, M.D.; J. Daniel Ragland, Ph.D.; Marjorie Solomon, Ph.D.; Cameron S. Carter, M.D.
Risperidone Nonadherence and Return of Positive Symptoms in the Early Course of Schizophrenia
Kenneth L. Subotnik, Ph.D.; Keith H. Nuechterlein, Ph.D.; Joseph Ventura, Ph.D.; Michael J. Gitlin, M.D.; Stephen Marder, M.D.; Jim Mintz, Ph.D.; Gerhard S. Hellemann, Ph.D.; Leslie A. Thornton, Ph.D.; Indira R. Singh, B.S.
CME   Abnormal Modulation of Amygdala Activity in Schizophrenia in Response to Direct- and Averted-Gaze Threat-Related Facial Expressions
Amy E. Pinkham, Ph.D.; James Loughead, Ph.D.; Kosha Ruparel, M.S.E.; Eve Overton, B.A.; Raquel E. Gur, M.D., Ph.D.; Ruben C. Gur, Ph.D
Copy Number Variants in Schizophrenia: Confirmation of Five Previous Findings and New Evidence for 3q29 Microdeletions and VIPR2 Duplications
Douglas F. Levinson, M.D.; Jubao Duan, Ph.D.; Sang Oh, M.Sc.; Kai Wang, Ph.D.; Alan R. Sanders, M.D.; Jianxin Shi, Ph.D.; Nancy Zhang, Ph.D.; Bryan J. Mowry, M.D., F.R.A.N.Z.C.P.; Ann Olincy, M.D.; Farooq Amin, M.D.; C. Robert Cloninger, M.D.; Jeremy M. Silverman, M.D.; Nancy G. Buccola, A.P.R.N., B.C.; William F. Byerley, M.D.; Donald W. Black, M.D.; Kenneth S. Kendler, M.D.; Robert Freedman, M.D.; Frank Dudbridge, Ph.D.; Itsik Pe'er, Ph.D.; Hakon Hakonarson, M.D., Ph.D.; Sarah E. Bergen, Ph.D.; Ayman H. Fanous, M.D.; Peter A. Holmans, Ph.D.; Pablo V. Gejman, M.D.
CME   Overactive Error-Related Brain Activity as a Candidate Endophenotype for Obsessive-Compulsive Disorder: Evidence From Unaffected First-Degree Relatives
Anja Riesel, Dipl.-Psych.; Tanja Endrass, Ph.D.; Christian Kaufmann, Dipl.-Psych.; Norbert Kathmann, Ph.D.
Response to Torrey Letter
Bernice A. Pescosolido, Ph.D.
Current Smoking, Hypoxia, and Suicide
Henri-Jean Aubin; Ivan Berlin; Michel Reynaud
Meta-Cognitive Therapy Without Metacognition: A Case of ADHD
Adrian Wells, Ph.D.; Peter Fisher, Ph.D.
Response to Wells and Fisher Letter
Mary V. Solanto, Ph.D.; Jeanette Wasserstein, Ph.D.; David J. Marks, Ph.D.
Response to Aubin et al. Letter
Namkug Kim, Ph.D.; Deborah A. Yurgelun-Todd, Ph.D.; Perry F. Renshaw, M.D., Ph.D.
Response to Nepon et al. Letter
Melanie S. Harned, Ph.D.; Shireen L. Rizvi, Ph.D.; Marsha M. Linehan, Ph.D.